Cargando…
The Treatment of COVID-19 With Monoclonal Antibody Therapy: Patient-Reported Outcomes
Objective There have been many efforts to research and produce treatment modalities for COVID-19. Monoclonal antibodies have been one of the effective treatments since their approval by the US Food and Drug Administration (FDA) under emergency use authorization (EUA) in 2020. This study surveyed COV...
Autores principales: | Lamour, Daniella, Vafadari, Nika, Clayton, Lisa M, Solano, Joshua J, Hughes, Patrick G, Shih, Richard D, Alter, Scott M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580605/ https://www.ncbi.nlm.nih.gov/pubmed/36277574 http://dx.doi.org/10.7759/cureus.29247 |
Ejemplares similares
-
Repeat Fall Risk in Geriatric Patients After Fall-Induced Head Trauma
por: Alter, Scott M, et al.
Publicado: (2023) -
The Role of Thromboelastography in Identifying Coagulopathy Among Geriatric Traumatic Brain Injury Patients
por: Busko, Alexander M, et al.
Publicado: (2022) -
Controversial COVID-19 Cures: Hydroxychloroquine and Oleander Pediatric Ingestion Simulation Cases
por: Solano, Joshua J, et al.
Publicado: (2022) -
A Comparison of the Adverse Effects and Utility of Different Monoclonal Antibodies for SARS-CoV-2: A Retrospective Cohort Study
por: Knopp, Brandon W, et al.
Publicado: (2023) -
Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment
por: Woltemate, Thomas J., et al.
Publicado: (2021)